BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7101272)

  • 21. Enhancement of natural killer cell activity in mice by treatment with a thymic factor.
    Bistoni F; Baccarini M; Puccetti P; Marconi P; Garaci E
    Cancer Immunol Immunother; 1984; 17(1):51-5. PubMed ID: 6563944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol.
    Baral E; Nagy E; Berczi I
    Cancer; 1995 Jan; 75(2):591-9. PubMed ID: 7812928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is thymosin action mediated by prostaglandin release?
    Rinaldi Garaci C; Favalli C; Del Gobbo V; Garaci E; Jaffe BM
    Science; 1983 Jun; 220(4602):1163-4. PubMed ID: 6574601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymosin modulation of suppressor function in mice and man.
    Serrou B; Rosenfeld C; Caraux J; Thierry C; Cupissol D; Goldstein A
    Ann N Y Acad Sci; 1979; 332():95-100. PubMed ID: 161154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymosin beta 4 enhances NK cell cytotoxicity mediated by ICAM-1.
    Lee HR; Yoon SY; Kang HB; Park S; Kim KE; Cho YH; Kim S; Kim CW; Cho BJ; Lee WJ; Bang SI; Park H; Cho D
    Immunol Lett; 2009 Mar; 123(1):72-6. PubMed ID: 19369144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of natural killer cell activity in mice treated with tobacco specific carcinogen NNK.
    Goud SN; Kaplan AM
    J Toxicol Environ Health A; 1999 Jan; 56(2):131-44. PubMed ID: 9972924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice.
    Marshall GD; Thurman GB; Rossio JL; Goldstein AL
    J Immunol; 1981 Feb; 126(2):741-4. PubMed ID: 6161188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of natural killer activity by thymosin alpha 1 and interferon.
    Favalli C; Jezzi T; Mastino A; Rinaldi-Garaci C; Riccardi C; Garaci E
    Cancer Immunol Immunother; 1985; 20(3):189-92. PubMed ID: 3851698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Refractoriness of mouse spleen rosette-forming cells to thymus hormones during the period of early postnatal ontogeny].
    Giulling EV; Nikol'skiĭ IS; Kravchuk GP; Ovsienko VV; Khaloimova IL
    Ontogenez; 1981; 12(1):100-2. PubMed ID: 7197341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction in vivo and in vitro of terminal deoxynucleotidyl transferase by thymosin in bone marrow cells from athymic mice.
    Pazmiño NH; Ihle JN; Goldstein AL
    J Exp Med; 1978 Mar; 147(3):708-18. PubMed ID: 632747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural cell-mediated immunity.
    Herberman RB; Holden HT
    Adv Cancer Res; 1978; 27():305-77. PubMed ID: 356546
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study of the effect of thymosin and supernatant from epithelial thymic cells on antibody production (author's transl)].
    Deschaux P; Fontanges R; Goldstein A
    Experientia; 1979 May; 35(5):678-81. PubMed ID: 376337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of in vitro generation of cell-mediated cytotoxicity. II. Characterization of thymosin-induced suppressor T cells.
    Marshall GD; Thurman GB; Goldstein AL
    Immunopharmacology; 1980 Dec; 2(4):301-12. PubMed ID: 6450736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of various thymic and nonthymic factors on in vitro antibody formation by spleen cells from nude mice.
    Blankwater MJ; Levert LA; Swart AC; van Bekkum DW
    Cell Immunol; 1978 Feb; 35(2):242-52. PubMed ID: 620432
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of thymic hormone treatment on several immune functions of nude mice.
    Ghanta VK; Hiramoto NS; Soong SJ; Hiramoto RN
    Mech Ageing Dev; 1991 May; 58(2-3):245-54. PubMed ID: 1875732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in viro effects of the fifth thymosin fraction.
    Litvinov VI; Averbakh MM; Novoselova VN; Gergert VY; Markov AN; Moroz AM
    Folia Biol (Praha); 1977; 23(3):218-21. PubMed ID: 328318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of the thymosin immunoregulatory effect by hypocorticoidism in rats with DMBA-induced carcinogenesis in mammary glands.
    Grinevich YuA ; Kamenets LYa
    Neoplasma; 1982; 29(1):19-27. PubMed ID: 6803177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Induction of activated natural killer cells by the streptococcal preparation OK432 (I). Induction from spleen cells of normal or tumor-bearing mouse primed in vivo and subsequently challenged in vitro with OK432].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1370-8. PubMed ID: 2809371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of intracellular actin of thymosin alpha-1 and thymic serum factor].
    Deschaux P; Doublet A; Fontanges R
    C R Seances Acad Sci III; 1982 Jan; 294(4):207-10. PubMed ID: 6282402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.